179 related articles for article (PubMed ID: 34378386)
1. Design, Synthesis, and Biological Evaluation of Stable Colchicine-Binding Site Tubulin Inhibitors 6-Aryl-2-benzoyl-pyridines as Potential Anticancer Agents.
Chen H; Deng S; Albadari N; Yun MK; Zhang S; Li Y; Ma D; Parke DN; Yang L; Seagroves TN; White SW; Miller DD; Li W
J Med Chem; 2021 Aug; 64(16):12049-12074. PubMed ID: 34378386
[TBL] [Abstract][Full Text] [Related]
2. Structure-Based Design and Synthesis of N-Substituted 3-Amino-β-Carboline Derivatives as Potent αβ-Tubulin Degradation Agents.
Li Y; Liu Y; Zhu Z; Yan W; Zhang C; Yang Z; Bai P; Tang M; Shi M; He W; Fu S; Liu J; Han K; Li J; Xie L; Ye H; Yang J; Chen L
J Med Chem; 2022 Feb; 65(3):2675-2693. PubMed ID: 35084853
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, antitumor activities and biological studies of novel diaryl substituted fused heterocycles as dual ligands targeting tubulin and katanin.
Gao F; Liang Y; Zhou P; Cheng J; Ding K; Wang Y
Eur J Med Chem; 2019 Sep; 178():177-194. PubMed ID: 31185410
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and biological evaluation of millepachine derivatives as a new class of tubulin polymerization inhibitors.
Wang G; Peng F; Cao D; Yang Z; Han X; Liu J; Wu W; He L; Ma L; Chen J; Sang Y; Xiang M; Peng A; Wei Y; Chen L
Bioorg Med Chem; 2013 Nov; 21(21):6844-54. PubMed ID: 23993668
[TBL] [Abstract][Full Text] [Related]
5. Design, Synthesis, and Bioactivity Evaluation of Dual-Target Inhibitors of Tubulin and Src Kinase Guided by Crystal Structure.
Wang L; Zheng Y; Li D; Yang J; Lei L; Yan W; Zheng W; Tang M; Shi M; Zhang R; Cai X; Ni H; Ma X; Li N; Hong F; Ye H; Chen L
J Med Chem; 2021 Jun; 64(12):8127-8141. PubMed ID: 34081857
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and anticancer properties of isocombretapyridines as potent colchicine binding site inhibitors.
Shuai W; Li X; Li W; Xu F; Lu L; Yao H; Yang L; Zhu H; Xu S; Zhu Z; Xu J
Eur J Med Chem; 2020 Jul; 197():112308. PubMed ID: 32339853
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological evaluation of a novel tubulin inhibitor 7a3 targeting the colchicine binding site.
Lai Q; Wang Y; Wang R; Lai W; Tang L; Tao Y; Liu Y; Zhang R; Huang L; Xiang H; Zeng S; Gou L; Chen H; Yao Y; Yang J
Eur J Med Chem; 2018 Aug; 156():162-179. PubMed ID: 30006162
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, molecular properties prediction and biological evaluation of indole-vinyl sulfone derivatives as novel tubulin polymerization inhibitors targeting the colchicine binding site.
Li W; Sun H; Xu F; Shuai W; Liu J; Xu S; Yao H; Ma C; Zhu Z; Xu J
Bioorg Chem; 2019 Apr; 85():49-59. PubMed ID: 30599412
[TBL] [Abstract][Full Text] [Related]
9. Development of triazolothiadiazine derivatives as highly potent tubulin polymerization inhibitors: Structure-activity relationship, in vitro and in vivo study.
Ma W; Chen P; Huo X; Ma Y; Li Y; Diao P; Yang F; Zheng S; Hu M; You W; Zhao P
Eur J Med Chem; 2020 Dec; 208():112847. PubMed ID: 33022479
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and bioevaluation of pyrazolo[1,5-a]pyrimidine derivatives as tubulin polymerization inhibitors targeting the colchicine binding site with potent anticancer activities.
Li G; Wang Y; Li L; Ren Y; Deng X; Liu J; Wang W; Luo M; Liu S; Chen J
Eur J Med Chem; 2020 Sep; 202():112519. PubMed ID: 32650183
[TBL] [Abstract][Full Text] [Related]
11. Structure-Activity Relationship Study of Novel 6-Aryl-2-benzoyl-pyridines as Tubulin Polymerization Inhibitors with Potent Antiproliferative Properties.
Chen H; Deng S; Wang Y; Albadari N; Kumar G; Ma D; Li W; White SW; Miller DD; Li W
J Med Chem; 2020 Jan; 63(2):827-846. PubMed ID: 31860298
[TBL] [Abstract][Full Text] [Related]
12. Discovery of a chiral fluorinated azetidin-2-one as a tubulin polymerisation inhibitor with potent antitumour efficacy.
Tang H; Cheng J; Liang Y; Wang Y
Eur J Med Chem; 2020 Jul; 197():112323. PubMed ID: 32339854
[TBL] [Abstract][Full Text] [Related]
13. (E)-N-Aryl-2-oxo-2-(3,4,5-trimethoxyphenyl)acetohydrazonoyl cyanides as tubulin polymerization inhibitors: Structure-based bioisosterism design, synthesis, biological evaluation, molecular docking and in silico ADME prediction.
Wang G; Peng Z; Peng S; Qiu J; Li Y; Lan Y
Bioorg Med Chem Lett; 2018 Nov; 28(20):3350-3355. PubMed ID: 30197030
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological evaluation of benz-fused five-membered heterocyclic compounds as tubulin polymerization inhibitors with anticancer activities.
Komuraiah B; Ren Y; Xue M; Cheng B; Liu J; Liu Y; Chen J
Chem Biol Drug Des; 2021 May; 97(5):1109-1116. PubMed ID: 33638903
[TBL] [Abstract][Full Text] [Related]
15. Discovery of novel quinazolines as potential anti-tubulin agents occupying three zones of colchicine domain.
Li W; Yin Y; Shuai W; Xu F; Yao H; Liu J; Cheng K; Xu J; Zhu Z; Xu S
Bioorg Chem; 2019 Mar; 83():380-390. PubMed ID: 30408650
[TBL] [Abstract][Full Text] [Related]
16. Discovery of novel N-benzylbenzamide derivatives as tubulin polymerization inhibitors with potent antitumor activities.
Zhu H; Li W; Shuai W; Liu Y; Yang L; Tan Y; Zheng T; Yao H; Xu J; Zhu Z; Yang DH; Chen ZS; Xu S
Eur J Med Chem; 2021 Apr; 216():113316. PubMed ID: 33676300
[TBL] [Abstract][Full Text] [Related]
17. Discovery of Novel Benzimidazole and Indazole Analogues as Tubulin Polymerization Inhibitors with Potent Anticancer Activities.
Ren Y; Wang Y; Li G; Zhang Z; Ma L; Cheng B; Chen J
J Med Chem; 2021 Apr; 64(8):4498-4515. PubMed ID: 33788562
[TBL] [Abstract][Full Text] [Related]
18. Design, Synthesis, and Biological Evaluation of 1-Methyl-1,4-dihydroindeno[1,2-c]pyrazole Analogues as Potential Anticancer Agents Targeting Tubulin Colchicine Binding Site.
Liu YN; Wang JJ; Ji YT; Zhao GD; Tang LQ; Zhang CM; Guo XL; Liu ZP
J Med Chem; 2016 Jun; 59(11):5341-55. PubMed ID: 27172319
[TBL] [Abstract][Full Text] [Related]
19. Identification and optimization of biphenyl derivatives as novel tubulin inhibitors targeting colchicine-binding site overcoming multidrug resistance.
Cheng B; Zhu G; Meng L; Wu G; Chen Q; Ma S
Eur J Med Chem; 2022 Jan; 228():113930. PubMed ID: 34794817
[TBL] [Abstract][Full Text] [Related]
20. Efficient Synthesis and Bioevaluation of Novel Dual Tubulin/Histone Deacetylase 3 Inhibitors as Potential Anticancer Agents.
Peng X; Chen J; Li L; Sun Z; Liu J; Ren Y; Huang J; Chen J
J Med Chem; 2021 Jun; 64(12):8447-8473. PubMed ID: 34097389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
